Welby Inc.

4438・Growth Market・Information & Communication

Official website

Welby Inc.

4438・Growth Market・Information & Communication

Official website

Welby Inc.4438

4438Growth MarketInformation & Communication

2nd Quarter of FY2026/12Earnings Call

PHR platform investment cycle now complete; Disease Solutions up +81.2%, with profitability to be driven by the twin pillars of disease-area platforms and the payer-facing business

August 31, 2026 at 19:57 GMT+9

4438Growth MarketInformation & Communication

2nd Quarter of FY2026/12Earnings Release

Disease Solutions revenue surged +81% YoY, driving overall revenue growth of +30.7%; with heavy H2 revenue weighting required, the key focus is whether the company can achieve its full-year guidance

August 13, 2026 at 20:17 GMT+9

4438Growth MarketInformation & Communication

2nd Quarter of FY2026/12Earnings Preview

2Q to test progress toward full-year revenue plan of +130.5%, driven by expanding PHR service and PHR platform orders in new therapeutic areas

August 10, 2026 at 15:30 GMT+9